Page last updated: 2024-10-19

niacinamide and Depressive Disorder, Major

niacinamide has been researched along with Depressive Disorder, Major in 3 studies

nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.

Depressive Disorder, Major: Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Colle, R1
Masson, P1
Verstuyft, C1
Fève, B1
Werner, E1
Boursier-Neyret, C1
Walther, B1
David, DJ1
Boniface, B1
Falissard, B1
Chanson, P1
Corruble, E1
Becquemont, L1
Zheng, P2
Chen, JJ1
Huang, T1
Wang, MJ1
Wang, Y2
Dong, MX1
Huang, YJ1
Zhou, LK1
Xie, P2
Chen, L1
Yang, D1
Meng, H1
Zhou, D1
Zhong, J1
Lei, Y1
Melgiri, ND1

Other Studies

3 other studies available for niacinamide and Depressive Disorder, Major

ArticleYear
Peripheral tryptophan, serotonin, kynurenine, and their metabolites in major depression: A case-control study.
    Psychiatry and clinical neurosciences, 2020, Volume: 74, Issue:2

    Topics: 3-Hydroxyanthranilic Acid; Adult; Case-Control Studies; Cohort Studies; Depressive Disorder, Major;

2020
A novel urinary metabolite signature for diagnosing major depressive disorder.
    Journal of proteome research, 2013, Dec-06, Volume: 12, Issue:12

    Topics: Adult; Biomarkers; Case-Control Studies; Depressive Disorder, Major; Dicarboxylic Acids; Discriminan

2013
Identification and validation of urinary metabolite biomarkers for major depressive disorder.
    Molecular & cellular proteomics : MCP, 2013, Volume: 12, Issue:1

    Topics: Adult; Alanine; Biomarkers; Depressive Disorder, Major; Female; Formates; Homovanillic Acid; Humans;

2013